Related references
Note: Only part of the references are listed.Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma
Jingya Yu et al.
CANCER LETTERS (2018)
MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN
Julia Ramirez-Moya et al.
ONCOGENE (2018)
Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines
Eleanor L. Woodward et al.
ENDOCRINE-RELATED CANCER (2017)
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Miguel Melo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis
Lei Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
TERT biology and function in cancer: beyond immortalisation
Ana Pestana et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Eleonora Molinaro et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
β-catenin downregulates Dicer to promote ovarian cancer metastasis
S. K. Y. To et al.
ONCOGENE (2017)
The ETS family of oncogenic transcription factors in solid tumours
Gina M. Sizemore et al.
NATURE REVIEWS CANCER (2017)
WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells
Kai Zhang et al.
CANCER RESEARCH (2017)
Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients
Young Shin Song et al.
CANCER (2016)
The changing incidence of thyroid cancer
Cari M. Kitahara et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
R. Rupaimoole et al.
ONCOGENE (2016)
Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAFV600E Mutation-Prevalent Population
Seung Eun Lee et al.
THYROID (2016)
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Tiantian Liu et al.
GENES (2016)
Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms
Kayla A. Lewis et al.
FRONTIERS IN GENETICS (2016)
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
Josh Lewis Stern et al.
GENES & DEVELOPMENT (2015)
Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis?
Miguel Melo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
TERT Promoter Mutation as an Early Genetic Event Activating Telomerase in Follicular Thyroid Adenoma (FTA) and Atypical FTA
Na Wang et al.
CANCER (2014)
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
G. Saretzki
CURRENT PHARMACEUTICAL DESIGN (2014)
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The ETS family member GABP alpha modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
Naomi L. Sharma et al.
NUCLEIC ACIDS RESEARCH (2014)
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
T. Liu et al.
ONCOGENE (2014)
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
Rajesha Rupaimoole et al.
NATURE COMMUNICATIONS (2014)
Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription
Deqiang Ding et al.
FASEB JOURNAL (2013)
Thyroid Cancer Cell Line Misidentification: An Update
Rebecca E. Schweppe
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Inigo Landa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors
Gavin D. Grant et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion
S. M. Jafarnejad et al.
ONCOGENE (2013)
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells
Z. Liu et al.
ONCOGENE (2013)
GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2
Zhong-Fa Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
The ETS Transcription Factors ELK1 and GABPA Regulate Different Gene Networks to Control MCF10A Breast Epithelial Cell Migration
Zaneta Odrowaz et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Telomerase and the endocrine system
Furio Pacini et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells
H. Prazeres et al.
ONCOGENE (2011)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Dicer1 functions as a haploinsufficient tumor suppressor
Madhu S. Kumar et al.
GENES & DEVELOPMENT (2009)
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models
Jia-Jing Lee et al.
THYROID (2007)